CompuGroup Medical SE & Co. KGaA (ETR:COP) has been given a €71.00 ($83.53) price objective by analysts at Baader Bank in a research report issued to clients and investors on Wednesday, Borsen Zeitung reports. The brokerage currently has a “sell” rating on the stock. Baader Bank’s price target would suggest a potential downside of 1.73% from the stock’s current price.
A number of other brokerages have also recently commented on COP. Deutsche Bank Aktiengesellschaft set a €88.00 ($103.53) price target on CompuGroup Medical SE & Co. KGaA and gave the company a “buy” rating in a research note on Friday, February 5th. Warburg Research set a €87.00 ($102.35) price target on CompuGroup Medical SE & Co. KGaA and gave the company a “buy” rating in a research note on Tuesday, March 16th. Finally, Berenberg Bank set a €85.00 ($100.00) target price on CompuGroup Medical SE & Co. KGaA and gave the stock a “neutral” rating in a research note on Tuesday, February 16th.
Shares of COP stock traded down €0.75 ($0.88) on Wednesday, reaching €72.25 ($85.00). The company had a trading volume of 81,248 shares, compared to its average volume of 68,245. The company has a current ratio of 1.06, a quick ratio of 0.93 and a debt-to-equity ratio of 86.79. The stock has a market cap of $3.88 billion and a PE ratio of 51.61. The company has a 50-day moving average of €71.41 and a 200-day moving average of €76.40. CompuGroup Medical SE & Co. KGaA has a 12 month low of €61.50 ($72.35) and a 12 month high of €85.40 ($100.47).
CompuGroup Medical SE & Co. KGaA Company Profile
CompuGroup Medical SE & Co KGaA develops and sells software and information technology solutions for the healthcare sector worldwide. It operates in four segments: Ambulatory Information Systems (AIS), Pharmacy Information Systems (PCS), Hospital Information Systems (HIS), and Consumer & Health Management Information Systems (CHS).
Read More: What is the Hang Seng index?
Receive News & Ratings for CompuGroup Medical SE & Co. KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CompuGroup Medical SE & Co. KGaA and related companies with MarketBeat.com's FREE daily email newsletter.